BRIEF published on 04/02/2024 at 15:05, 2 years 4 months ago Edesa Biotech participera aux prochaines conférences d'investisseurs Immunothérapie Essais Cliniques Produits Biopharmaceutiques Edesa Biotechnologie Conférences Investisseurs
PRESS RELEASE published on 04/02/2024 at 15:00, 2 years 4 months ago Edesa Biotech to Participate in Upcoming Investor Conferences Edesa Biotech, Inc. announces participation in upcoming investor conferences in Toronto, London, and New York to present innovative treatments for immuno-inflammatory diseases Clinical-stage Biopharmaceutical Company Immuno-inflammatory Diseases Investor Conferences Edesa Biotech Inc. Therapeutics
BRIEF published on 03/21/2024 at 21:35, 2 years 5 months ago Edesa Biotech participera à la conférence HC Wainwright sur les maladies auto-immunes et inflammatoires Maladies Inflammatoires Edesa Biotechnologie Conférence Auto-immune Discussion Au Coin Du Feu Produits Biopharmaceutiques Au Stade Clinique
BRIEF published on 03/21/2024 at 21:35, 2 years 5 months ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Fireside Chat Edesa Biotech Inflammatory Diseases Autoimmune Conference Clinical-Stage Biopharmaceutical
PRESS RELEASE published on 03/21/2024 at 21:30, 2 years 5 months ago Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference Edesa Biotech to participate in H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference. Fireside Chat with CEO Par Nijhawan, MD and analyst scheduled for March 28, 2024 Fireside Chat Edesa Biotech H.C. Wainwright Autoimmune & Inflammatory Disease Par Nijhawan
BRIEF published on 03/07/2024 at 14:50, 2 years 5 months ago Edesa Biotech to Showcase at Barclays Global Healthcare Conference Clinical Trials Edesa Biotech Immunotherapy Barclays Healthcare Conference ARDS
BRIEF published on 03/07/2024 at 14:50, 2 years 5 months ago Edesa Biotech sera présent à la conférence Barclays Global Healthcare Immunothérapie Essais Cliniques Edesa Biotechnologie Conférence Barclays Sur La Santé SDRA
PRESS RELEASE published on 03/07/2024 at 14:45, 2 years 5 months ago Edesa Biotech to Participate in Barclays Global Healthcare Conference Edesa Biotech, Inc. (NASDAQ:EDSA) to participate in Barclays 26th Annual Global Healthcare Conference in Miami. Company focuses on developing host-directed therapeutics for immuno-inflammatory diseases Biopharmaceutical Company Edesa Biotech NASDAQ:EDSA Barclays 26th Annual Global Healthcare Conference Immune-related Diseases
BRIEF published on 03/04/2024 at 22:35, 2 years 5 months ago Edesa Biotech participera aux prochaines réunions de dermatologie Biopharmaceutique Essais Cliniques Edesa Biotechnologie Dermatologie Maladies Immuno-inflammatoires
BRIEF published on 03/04/2024 at 22:35, 2 years 5 months ago Edesa Biotech to Participate in Upcoming Dermatology Meetings Immuno-inflammatory Diseases Clinical Trials Biopharmaceutical Edesa Biotech Dermatology
Published on 09/01/2026 at 23:05, 5 hours 12 minutes ago Aton Announces US$30M Credit Facility with OU Moonrider
Published on 09/01/2026 at 22:30, 5 hours 47 minutes ago Algo Grande Copper Closes Oversubscribed Private Placement for $4.786 Million
Published on 09/01/2026 at 22:15, 6 hours 2 minutes ago NuRAN Wireless Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
Published on 09/01/2026 at 16:10, 12 hours 7 minutes ago Sparton Signs Definitive Morrison Silver Mine Option and Joint Venture Agreement with Glen Eagle; Appoints Vice President, Corporate Development
Published on 09/02/2026 at 02:05, 2 hours 12 minutes ago Sceye and SoftBank Corp. Complete Stratospheric Connectivity Demonstration in Japan, Advancing Towards HAPS Commercialization
Published on 09/02/2026 at 01:05, 3 hours 12 minutes ago Clean electricity supplied 40% of new energy demand in 2025. Faster deployment and sectoral breakthroughs can cut emissions permanently, says annual Energy Transition Monitor
Published on 09/01/2026 at 22:00, 6 hours 17 minutes ago MHM CORPORATE - Publication of unaudited half-year 2026 financial information
Published on 09/01/2026 at 22:00, 6 hours 17 minutes ago MHM CORPORATE - Publication d'informations financières semestrielles 2026 non auditées
Published on 09/01/2026 at 20:07, 8 hours 10 minutes ago EQS-Adhoc: HUGO BOSS AG: HUGO BOSS TERMINATES SHARE BUYBACK PROGRAM
Published on 09/01/2026 at 19:00, 9 hours 17 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 09/01/2026 at 19:00, 9 hours 17 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 09/01/2026 at 18:18, 9 hours 59 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Août 2026
Published on 09/01/2026 at 18:18, 9 hours 59 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - August 2026
Published on 09/01/2026 at 17:44, 10 hours 33 minutes ago Reporting on share buyback transactions carried out between August 18 and August 28, 2026
